Quantum Genomics (Quantum Genomics) Change In Inventory : $0.00 Mil (TTM As of Dec. 2022)

View and export this data going back to 2017. Start your Free Trial

What is Quantum Genomics Change In Inventory?

Quantum Genomics's change in inventory for the quarter that ended in Dec. 2022 was $0.00 Mil. It means Quantum Genomics's inventory stayed the same from Jun. 2022 to Dec. 2022 .

Quantum Genomics's change in inventory for the fiscal year that ended in Dec. 2022 was $0.00 Mil. It means Quantum Genomics's inventory stayed the same from Dec. 2021 to Dec. 2022 .

Quantum Genomics's Total Inventories for the quarter that ended in Dec. 2022 was $0.00 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Quantum Genomics's Days Inventory for the quarter that ended in Dec. 2022 was 0.00.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Quantum Genomics Change In Inventory Historical Data

The historical data trend for Quantum Genomics's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quantum Genomics Change In Inventory Chart

Quantum Genomics Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Change In Inventory

Get a 7-Day Free Trial

-0.20

0.10

-1.72

Quantum Genomics Semi-Annual Data
	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22
Change In Inventory	Get a 7-Day Free Trial															-0.82	2.11	-	-	-

Quantum Genomics Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2022 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00 Mil.

Quantum Genomics (OTCPK:QNNTF) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Quantum Genomics's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	0	/	26.485	*	365 / 2
	=	0.00

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Quantum Genomics's Inventory Turnover for the quarter that ended in Dec. 2022 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	26.485	/	0
	=	N/A

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Quantum Genomics's Inventory to Revenue for the quarter that ended in Dec. 2022 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0	/	-0.309
	=	N/A

Quantum Genomics Change In Inventory Related Terms

Thank you for viewing the detailed overview of Quantum Genomics's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Quantum Genomics (Quantum Genomics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Quantum Genomics (OTCPK:QNNTF) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

ALQGC:France 2QG:Germany

Address

33, Rue Marbeuf, Paris, FRA, 75008

Website

https://quantum-genomics.com

Quantum Genomics is a biopharmaceutical company engaged in developing new products for unmet needs in the field of cardiovascular diseases, high blood pressure, and heart failure. The company products include firibastat, QGC006, QGC011, and others.